Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Apellis Pharmaceuticals (APLS) Inventory Average (2021 - 2025)

Apellis Pharmaceuticals filings provide 5 years of Inventory Average readings, the most recent being $132.7 million for Q4 2025.

  • For the quarter ending Q4 2025, Inventory Average rose 31.07% year-over-year to $132.7 million, compared with a TTM value of $132.7 million through Dec 2025, up 31.07%, and an annual FY2025 reading of $112.0 million, down 1.67% over the prior year.
  • Inventory Average hit $132.7 million in Q4 2025 for Apellis Pharmaceuticals, up from $121.9 million in the prior quarter.
  • The five-year high for Inventory Average was $157.0 million in Q2 2024, with the low at $2.7 million in Q3 2021.
  • Median Inventory Average over the past 5 years was $97.6 million (2023), compared with a mean of $88.6 million.
  • The sharpest move saw Inventory Average soared 1900.81% in 2022, then tumbled 46.73% in 2025.
  • Year by year, Inventory Average stood at $9.0 million in 2021, then soared by 709.81% to $72.7 million in 2022, then skyrocketed by 68.36% to $122.5 million in 2023, then fell by 17.33% to $101.2 million in 2024, then surged by 31.07% to $132.7 million in 2025.
  • According to Business Quant data, Inventory Average over the past three periods came in at $132.7 million, $121.9 million, and $101.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.